China Chemical Pharmaceutical Market Report, 2008
  • Dec/2008
  • Hard Copy
  • USD $1,700
  • Pages:81
  • Single User License
    (PDF Unprintable)       
  • USD $1,800
  • Code: EB004
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $2,700
  • Hard Copy + Single User License
  • USD $1,900

By the end of Aug, 2008, the total output value of China’s chemical pharmaceutical industry was CNY 273.272 billion, among which, the total output value of active pharmaceutical ingredient (API) was CNY 122.467 billion and the total output value of chemical reagent was CNY 150.805 billion.

Total Output Value of China’s Chemical Pharmaceutical Industry, 2004-2008
Source: ResearchInChina

By the end of Sep, 2008, the total output of active pharmaceutical ingredient (API) in China was 1.675 million tons, of which, the output in Q12008 reached as many as 783,000 tons, up by 73.2% compared to Q1 2007.

API Output in China, 2005Q1-2008Q3
Source: ResearchInChina

This report gives an in-depth analysis of China’s chemical pharmaceutical industry, covering market segmentations, main products, and regional markets in China as well as the key players.

1. Overview of China Chemical Pharmaceutical Industry 
1.1 Development Course
1.2 Classification of Chemical Pharmaceutical Companies 
1.2.1 Reagent Manufacturers 
1.2.2 Active Pharmaceutical Ingredient (API) Manufacturers 

2. Overview of China Chemical Pharmaceutical Market 
2.1 Overview of The Market 
2.2 Characteristics of The Chemical Pharmaceutical Companies 

3.  China Active Pharmaceutical Ingredients (API) Market 
3.1 Overview of the Market
3.2 Market Performance 
3.2.1 Sales
3.2.2 Losses 
3.3 API Import & Export 
3.3.1 Export 
3.3.2 Import
3.4 Competition Patterns 
3.5 Market Performance of Major API Products
3.5.1 Cephalosporins
3.5.2 Vitamin C
3.5.3 Amoxycillin
3.5.4 Ceftriaxone Sodium
3.5.5 Clarithromycin

4. China Chemical Reagent Market 
4.1 Overview of the Market 
4.2 Market Performance 
4.2.1 Sales 
4.2.1 Losses
4.3 Import & Export
4.4 Market Performance of Major Reagent Products 
4.4.1 Lipitor
4.4.2 Clopidogrel
4.4.3 Rituximab
4.4.4 Fluticasone/Salmeterol
4.4.5 Epoetin Alfa
4.4.6 Single Nitroglycerin
4.4.7 Isosorbide dinitrate
4.4.8 Nitroglycerin

5. Regional Chemical Pharmaceutical Markets in China 
5.1 Overview
5.2 Shandong Province  
5.2.1 Overview 
5.2.2 Market Performance
5.2.3 Competition Patterns 
5.3 Jiangsu Province 
5.3.1 Overview 
5.3.2 Market Performance 
5.3.3 Competition Patterns
5.4 Zhejiang Province
5.4.1 Overview
5.4.2 Market Performance
5.4.3 Competition Patterns 
5.5 Hebei Province 
5.5.1 Overview 
5.5.2 Market Performance 
5.5.3 Competition Patterns 

6. Analysis of Key Companies 
6.1 Northeast Pharmaceutical Group Co., Ltd. 
6.1.1 Company Profile
6.1.2 Operations
6.2 Hubei Biocause Pharmaceutical Co., Ltd. 
6.2.1 Company Profile
6.2.2 Operations
6.3 Apeloa Co., Ltd. 
6.3.1 Company Profile
6.3.2 Operations
6.4 Shandong Xinhua Pharmaceutical Co., Ltd. 
6.4.1 Company Profile
6.4.2 Operations
6.5 Southwest Synthetic Pharmaceutical Co. Ltd.
6.5.1 Company Profile
6.5.2 Operations
6.6 Anhui Fengyuan Pharmaceutical Co., Ltd. 
6.6.1 Company Profile
6.6.2 Operations
6.7 LIVZON Pharmaceutical Group Inc.
6.7.1 Company Profile
6.7.2 Operations
6.8 Guangzhou Baiyunshan Pharmaceutical Co., Ltd.
6.8.1 Company Profile
6.8.2 Operations
6.9 Beijing Double-Crane Pharmaceutical Co., Ltd. 
6.9.1 Company Profile
6.9.2 Operations
6.10 Hainan Haiyao Co., Ltd. 
6.10.1 Company Profile
6.10.2 Operations
Total Output Value of China Chemical Pharmaceutical Industry, 2004-2008 
Sales Revenue of China Chemical Pharmaceutical Industry, 2005-2008 
The Proportion of Large and Medium-sized Chemical Pharmaceutical Companies in China in 2007 
Assets of Chemical Pharmaceutical Companies in China by Size, Jan.-Nov.2007 
Losses of Chemical Pharmaceutical Companies in China by Size, Jan.-Nov.2007
API Output in China, 2005Q1-2008Q3
Output Value of API in China, 2005-2008 
Sales of API in China, 2005-2008 
Sales / Output Ratio of API in China, 2005-2008  
Accumulated Losses of API Manufacturers in China, 2006-2008 
China API Export Value, 2005-2008 
China API Import Value, 2005-2008 
Sales Revenue and Assets of China Top Ten API Manufacturers, Sep.2008 
Vitamin C Price in China, 2007-2008 
Total Output Value of Chemical Reagent in China, 2006-2008 
Sales of Chemical Reagent in China, 2006-2008
Sales / Output Ratio of Chemical Reagent in China, 2006-2008 
The Number of Chemical Reagent Manufacturers in Loss, 2006-2008 
Accumulated Losses of Chemical Reagent Manufacturers in China, 2006-2008 
China Monthly Antibiotic Reagent Import, 2007-2008 
Global Lipitor Sales, 2002-2008
Corresponding Proportion Taken by Nitrate Esters Medicines in 2007 
Top Ten Provinces by Chemical Pharmaceutical Assets in China in 2007 
Top Ten Provinces by Chemical Pharmaceutical Sales in China in 2007 
Top Ten Provinces by Chemical Pharmaceutical Output in China in 2007 
Regional Distribution of Chemical Pharmaceutical Companies in China, Jan.-Nov.2007 
Gross Profit Margin of Chemical Pharmaceutical in Shandong Province, 2004-2007 
Profits of API and Chemical Reagent in Shandong Province in 2007 
Top Five API Manufacturers in Shandong Province in 2007  
Top Five Chemical Reagent Manufacturers in Shandong Province in 2007 
Gross Profit Margin of Chemical Pharmaceutical in Jiangsu Province, 2004-2007 
Profits of API and Chemical Reagent in Jiangsu Province in 2007 
Top Five API Manufacturers in Jiangsu Province in 2007  
Top Five Chemical Reagent Manufacturers in Jiangsu Province in 2007 
Gross Profit Margin of Chemical Pharmaceutical in Zhejiang Province, 2004-2007 
Profits of API and Chemical Reagent in Zhejiang Province in 2007 
Top Five API Manufacturers in Zhejiang Province in 2007  
Top Five Chemical Reagent Manufacturers in Zhejiang Province in 2007 
The Number of Chemical Pharmaceutical Companies in Hebei Province in 2007 
Gross Profit Margin of Chemical Pharmaceutical in Hebei Province, 2004-2007 
Profits of API and Chemical Reagent in Hebei Province in 2007 
Top Five API Manufacturers in Hebei Province in 2007  
Top Five Chemical Reagent Manufacturers in Hebei Province in 2007 
Sales Revenue of Northeast Pharmaceutical Group Co., Ltd., 2001-2008 
API Revenue of Northeast Pharmaceutical Group Co., Ltd., 2005-2008
Chemical Reagent Revenue of Northeast Pharmaceutical Group Co., Ltd., 2005-2008
Regional Sales Revenue of Northeast Pharmaceutical Group Co., Ltd, Jun.2008
Sales Revenue of Hubei Biocause Pharmaceutical Co., Ltd., 2005-Jun.2008
Production Capacity of Hubei Biocause Pharmaceutical Co., Ltd.
Regional Sales Revenue of Hubei Biocause Pharmaceutical Co., Ltd in 2008
API Revenue of Hubei Biocause Pharmaceutical Co., Ltd., 2005-2008
Chemical Reagent Revenue of Hubei Biocause Pharmaceutical Co., Ltd., 2005-2008
Sales Revenue of Apeloa Co., Ltd., 2003-2008 
API Revenue of Apeloa Co., Ltd., 2003-2008

China Vitamin Industry Report,2014-2017

China is the world's largest production base of vitamins, with vitamin C and vitamin E as its most important products, wherein vitamin C and related products account for more than 60% of its total out...

China Chemical Pharmaceutical Industry Report, 2013-2016

Chemical pharmaceutical consists mainly of chemical drug preparation and active pharmaceutical ingredient (API), and the gross margin of chemical drug preparation industry is generally higher than tha...

China Pharmaceutical Distribution Industry Report, 2013

Thanks to the continuous advancement in new medical reform, China’s pharmaceutical distribution industry has maintained a fairly rapid growth in recent years, with the sales value showed a CAGR of rou...

China Pharmaceutical Glass Packaging Industry Report, 2013-2016

Influenced by the substitution of plastic, aluminum foil and other new packaging materials as well as the declining packaging material purchase prices incurred by the medical reform, China pharmaceuti...

China Chinese Patent Medicine Industry Report, 2013-2016

Chinese patent medicine refers to the certain dosage forms of medicine, under the guidance of TCM (traditional Chinese medicine) theory, made from traditional Chinese medicinal materials in accordance...

Global and China Monoclonal Antibody Industry Report, 2013-2017

Currently, monoclonal antibody agents have been successfully used in the treatment of tumors, cancers and other serious diseases as a heavyweight in the biopharmaceutical industry. In 2009-2012, the m...

Global and China Insulin Industry Report, 2013-2017

As the third largest human health disease following neoplastic disease, cardiovascular and cerebrovascular diseases, the number of diabetic patients has continued growing from 246 million in 2007 to 3...

China Large Volume Parenteral (LVP) Industry Report, 2013-2015

Under the context of China's medical reform and sustainable development of the pharmaceutical market, the output and demand of Large Volume Parenteral (LVP) which is one of the top five Chinese prepar...

China Independent Clinical Laboratory Industry Report,2013-2015

Restricted by the health care system and the medical inspection level (Chinese firms mainly lag behind foreign counterparts in molecular diagnostics and other special tests), Chinese independent clini...

China Vitamin Industry Report, 2012-2015

As a great power of vitamin production and export, China has long been known as the world’s vitamin production base. In recent years, its vitamin exports on external demand accounted for about 80% of ...

China Pharmaceutical Equipment Industry Report, 2012-2015

Driven by the new GMP certification as well as the brisk downstream demand, China pharmaceutical equipment industry has seen steady progress in sales volume and technological content of products over ...

China Genetic Engineering Drug Industry Report, 2011-2012

China gets a late start in developing genetic engineering drug industry, but has achieved leapfrog advance. At present, China has at least one hundred enterprises involved in genetic engineering drugs...

China Animal Vaccine Industry Report, 2011-2012

Along with the frequent outbreaks of animal epidemics, the government’s increasing investment in epidemic prevention and the implementation of compulsory immunization system, Chinese animal vaccine ma...

China Human Vaccine Industry Report, 2011-2012

After decades of development, China has become one of the major producer and consumers of human vaccine around the world. In 2011, human vaccine manufacturers numbered 38 in China and the lot release ...

China Chemical Pharmaceutical Industry Report, 2011

In Jan.-Aug., 2011, the gross industrial output value of Chinese chemical pharmaceutical industry surged by 24.54% YoY to RMB460.531 billion, up 2.67 percentage points over the same period of last yea...

China Pharmaceutical Equipment Industry Report, 2011-2012

In recent years, Chinese pharmaceutical equipment industry has witnessed significant growth in both product quality and technological content, as well as steady rise of sales volume. According to Chin...

China Animal Vaccine Industry Report, 2010-2011

China animal vaccine industry has been fast-growing. The market maintained an average annual growth rate up to 13.6% in 2006-2010, and reached around RMB 7.5 billion in 2010, up 21.0% YoY. With the in...

China Human Vaccine Industry Report, 2010-2011

With the improvement of economy and people’s disease prevention awareness, China’s human vaccine market has expanded in recent years, growing at a CAGR of 24.0% in 2007-2010. In particular, the market...

2005-2014 All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号